Philip Gutin, Eric Holland, and Lisa DeAngelis lead the BTC, which conducts basic, translational, and clinical research to improve treatment for central nervous system tumors.
Eric Holland, Director of the Brain Tumor Center, is a neurosurgeon and researcher who studies the molecular changes that occur in glioblastoma and other brain tumors.
Neuro-oncologist Antonio Omuro specializes in treating different types of brain tumors and is currently the principal investigator for a wide range of clinical trials at Memorial Sloan-Kettering.
Radiologist Moritz Kircher uses molecular imaging to study what is happening within individual tumor cells noninvasively, which could allow brain tumors to be diagnosed, classified, and treated in more-precise ways in the future.
With the support of the F. M. Kirby Foundation, the BTC annually funds top research proposals submitted by faculty who are conducting clinical and/or basic science research related to brain tumors.
